LEADER 02004nam  2200361   450 
001 9910678589603321
005 20230502075932.0
010   $a1-80356-366-4
035   $a(CKB)5840000000237830
035   $a(NjHacI)995840000000237830
035   $a(EXLCZ)995840000000237830
100   $a20230502d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aLiposomes $eRecent Advances, New Perspectives and Applications /$fRajeev K. Tyagi, Nikunj Tandel, editors
210  1$aLondon :$cIntechOpen,$d2023.
215   $a1 online resource (120 pages)
311   $a1-80356-365-6 
330   $aThe role of nanoscale drug carriers for the effective and controlled delivery of drugs and candidate antigens is instrumental in developing therapeutic and vaccine interventions for cancers, infectious diseases and beyond. As teachers of immunobiology, we think this information will contribute to the development of interventional approaches. This book, therefore, will be a valuable addition to existing knowledge in many medical schools and undergraduate courses, providing up-to-date information on drugs and their delivery for maximum therapeutic effect and vaccination potential against infectious diseases, cancers and more. Novel drugs are described, with an assessment of their effective delivery and of drug resistance, especially against cancers. The book is a timely addition to the existing literature on lipid-based nanoparticles and will be a useful resource for students, researchers, and those working in the field of drugs, drug delivery, and drug resistance in infectious and inflammatory diseases.
606   $aLiposomes
615  0$aLiposomes.
676   $a615.7
702   $aTandel$b Nikunj
702   $aTyagi$b Rajeev K.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910678589603321
996   $aLiposomes$983649
997   $aUNINA